Skip to content
Kalpvruksh Markets
Offline Log in

SYNGENENSEOffline

SYNGENE INTERNATION. · INE398R01022 · Small Cap · #369
414.10−3.40 (−0.81%)last close · 05 Nov 2026
Prev close
417.50
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹18,672 cr
52-week range · to 05 Nov 2026346663.85

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

SYNGENE is 38% below its 52-week high, below its 200-day average, ahead of Healthcare by 0.8 pts over 3 months — a Small Cap company, #369 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50-day averages · below its 200-day average · 38% below its 52-week high
  • ahead of its industry by 0.8 pts over 3 months · rank 11 of 44 in Healthcare · +4.0% vs Nifty 500
  • traded value 2.0× usual · delivery 43% vs 52% usual
  • FPI −1.7 pp · DII +1.3 pp · MF schemes in Sept 2026: 32 bought, 41 cut · no promoter pledge · quarter ended 2026-09-30
  • Sept 2026 quarter: profit −52% year on year · revenue −9%
  • ftse large_mid: delete candidate (2027-03)

How big is it?

six-month average market cap

Market capitalisation
₹18,672 cr
Rank
#369
Cap band
Small Cap
Nearest cut-off — Mid / Small
−45.39% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
0.7×
median 5,04,991
Delivered
3,41,266
Of volume
52%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+3.9%−1.9 pts—
1 month+14.0%+9.0 pts+9.7 pts
3 months+1.8%+4.0 pts+0.8 pts
6 months−8.0%−8.4 pts−17.0 pts
1 year−36.4%−34.7 pts—

Industry: Healthcare (Nifty 500 classification) · rank 11 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+7.4%
above
vs 50-day average
+7.6%
above
vs 200-day average
−2.8%
below
ATR (14)
4.8%
typical daily range
Volatility
60%
1 month, annualised
Beta
0.80
vs Nifty 500, 1 year
Traded value
2.0×
vs usual
Delivery
43%
usual 52%
From the 52-week high
−37.6%
place in range 21% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters52.7%52.7%52.6% −0.152.6%
FPI15.0%13.9% −1.111.8% −2.110.1% −1.7
Mutual funds22.7%24.2% +1.525.8% +1.627.1% +1.3
Other DII3.1%2.3% −0.92.2%2.2%
Individuals5.4%5.5% +0.16.1% +0.66.3% +0.1
Others1.2%1.5% +0.31.4%1.7% +0.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
1,34,008
Individuals
1,26,543

Indian passive funds’ stake

2026-06-30

Of free float
0.82%
Of all shares
0.39%
Schemes
54
Days to unwind
0.7
at 100% of volume

15,75,647 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
116
54 index · 62 active
Bought more
61
Sold some
15
FundSharesChangeDid
SBI Balanced Advantage Fund-Reg(G)Active+7,00,218+3432.4%bought
HSBC Midcap Fund-Reg(G)Active+35,42,742+270.8%bought
DSP Healthcare Fund-Reg(G)Active+7,31,953+195.0%bought
UTI Flexi Cap Fund-Reg(IDCW)Active−19,56,000−84.3%sold
UTI ULIP(G)Active−1,59,703−74.4%sold
Invesco India Aggressive Hybrid Fund-Reg(G)Active−15,029−27.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2610810223011+1.8%₹3,851 cr
Aug 261091845912+0.2%₹4,148 cr
Jul 26103741188+2.1%₹3,988 cr
Jun 26104739168−0.6%₹4,451 cr
May 26105334224+3.4%₹4,504 cr
Apr 26106453125+4.3%₹4,610 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 10 of 104 disclosures
0 selected
10 Dec 2024Biocon LimitedPromotersSell80,00,000₹686 cr52.46%Market Sale
07 Nov 2024SIBAJI BISWASKey Managerial PersonnelBuy86,431₹7.69 cr0.04%ESOP
07 Nov 2024SIBAJI BISWASKey Managerial PersonnelSell35,000₹3.2 cr0.03%Market Sale
16 Aug 2024Priyadarshini MahapatraKey Managerial PersonnelSell4,500₹0.37 cr0.00%Market Sale
16 Aug 2024Priyadarshini MahapatraKey Managerial PersonnelSell4,500₹0.37 cr0.00%Market Sale
12 Aug 2024JONATHAN BRITTAN HUNTKey Managerial PersonnelBuy1,38,291₹11.29 cr0.09%ESOP
12 Aug 2024JONATHAN BRITTAN HUNTKey Managerial PersonnelSell1,28,291₹10.64 cr0.06%Market Sale
12 Aug 2024JONATHAN BRITTAN HUNTKey Managerial PersonnelSell10,000₹0.83 cr0.09%Market Sale
09 Aug 2024Priyadarshini MahapatraKey Managerial PersonnelBuy10,000₹0.85 cr0.01%ESOP
09 Aug 2024Priyadarshini MahapatraKey Managerial PersonnelSell3,900₹0.33 cr0.00%Market Sale

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Syngene International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    28 Oct 2026
  • Scheme / acquisition
    Syngene International Limited has informed the Exchange about Acquisition
    25 Aug 2026
  • Scheme / acquisition
    Acquisition (including agreement to acquire)-XBRL SYNGENE INTERNATIONAL LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire)
    25 Aug 2026
  • Board outcome
    Syngene International Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    30 Jul 2026

SYNGENE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹1.25Final25 Jun 202626 Jun 2026
EarlierDividend₹1.25Final27 Jun 202527 Jun 2025
EarlierDividend₹1.25Final28 Jun 202428 Jun 2024
EarlierDividend₹0.75Special30 Jun 202330 Jun 2023
EarlierDividend₹0.5Final30 Jun 202330 Jun 2023
EarlierDividend₹0.5Final30 Jun 202201 Jul 2022
EarlierBonus1:1—11 Jun 201912 Jun 2019

7 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.